ArticleBMJ open2023

Combining chemotherapy and tislelizumab with preoperative split-course hypofraction radiotherapy for locally advanced rectal cancer: study protocol of a prospective, single-arm, phase II trial.

Rong Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.